{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:26:56Z","timestamp":1791905216199,"version":"4.3.4"},"reference-count":66,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Psoriasis is an increasingly common chronic immune-mediated skin disease recognized for its systemic effects that extend beyond the skin and include various cardiovascular diseases, neurological diseases, type 2 diabetes, and metabolic syndrome. This study aimed to explore the complex relationship between psoriasis and metabolic syndrome by analyzing clinical, biochemical, and immunological parameters in patients with psoriasis alone and in patients combining psoriasis and metabolic syndrome. A total of 150 patients were enrolled, 76 with psoriasis only (PSO) and 74 with psoriasis and metabolic syndrome (PSO\u2013MS). Data collected included anthropometric measurements, blood tests, and inflammatory markers. Statistical analysis was performed using the independent t-test, Mann\u2013Whitney U test, Kruskal\u2013Wallis test, and chi-square test to compare the two groups. Patients in the PSO\u2013MS group had a significantly higher body weight, abdominal circumference, BMI, and inflammatory markers compared to patients with PSO. In addition, increased levels of IL-17A, cholesterol, triglycerides, and glucose were observed in the PSO\u2013MS group. This study highlights the increased metabolic risk and exacerbated systemic inflammation associated with the coexistence of psoriasis and metabolic syndrome. These findings demonstrate the need for a comprehensive therapeutic approach and early intervention to manage metabolic complications in patients with psoriasis and metabolic syndrome.<\/jats:p>","DOI":"10.3390\/diagnostics14161774","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T10:28:41Z","timestamp":1723631321000},"page":"1774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Implications of Metabolic Syndrome in Psoriasis Management"],"prefix":"10.3390","volume":"14","author":[{"given":"Maria-Lorena","family":"Mustata","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7150-5987","authenticated-orcid":false,"given":"Carmen-Daniela","family":"Neagoe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Ionescu","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Predoi","sequence":"additional","affiliation":[{"name":"Department of Morphology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Mitran","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona-Laura","family":"Ianosi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Costache, D.O., Bejan, H., Poenaru, M., and Costache, R.S. (2023). Skin Cancer Correlations in Psoriatic Patients. Cancers, 15.","DOI":"10.3390\/cancers15092451"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13671-013-0066-6","article-title":"Genetic Epidemiology of Psoriasis","volume":"3","author":"Gupta","year":"2014","journal-title":"Curr. Dermatol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0001-7310(09)73372-1","article-title":"Progress in Understanding the Immunopathogenesis of Psoriasis","volume":"100","author":"Mak","year":"2009","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/nutd.2012.26","article-title":"The Association between Psoriasis and Obesity: A Systematic Review and Meta-Analysis of Observational Studies","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr. Diabetes"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"adv11640","DOI":"10.2340\/actadv.v103.11640","article-title":"Factors Influencing Major Life-Changing Decisions in Patients with Psoriasis: A Cross-Sectional Study","volume":"103","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"ref_7","unstructured":"Swarup, S., Ahmed, I., Grigorova, Y., and Zeltser, R. (2024). Metabolic Syndrome. StatPearls, StatPearls Publishing."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jcp.2007.048363","article-title":"Clinical and Laboratory Diagnosis of the Metabolic Syndrome","volume":"61","author":"Olufadi","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hernandez-Baixauli, J., Quesada-V\u00e1zquez, S., Marin\u00e9-Casad\u00f3, R., Gil Cardoso, K., Caimari, A., Del Bas, J.M., Escot\u00e9, X., and Baselga-Escudero, L. (2020). Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment. Nutrients, 12.","DOI":"10.3390\/nu12030806"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.trsl.2015.06.017","article-title":"Targeting Inflammation in Metabolic Syndrome","volume":"167","author":"Welty","year":"2016","journal-title":"Transl. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187152812800392805","article-title":"The IL23\/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases","volume":"11","author":"Toussirot","year":"2012","journal-title":"Inflamm. Allergy-Drug Targets"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/etm.2021.11102","article-title":"Metabolic Comorbidities of Psoriasis (Review)","volume":"23","author":"Branisteanu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_13","first-page":"7353420","article-title":"Biomarkers of Inflammation in Obesity-Psoriatic Patients","volume":"2019","author":"Fabbrocini","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"802078","DOI":"10.1155\/2010\/802078","article-title":"The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases","volume":"2010","author":"Balistreri","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kim, J.-E., Kim, J.-S., Jo, M.-J., Cho, E., Ahn, S.-Y., Kwon, Y.-J., and Ko, G.-J. (2022). The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome. Molecules, 27.","DOI":"10.3390\/molecules27020334"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and Metabolic Syndrome: A Systematic Review and Meta-Analysis of Observational Studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.120237","article-title":"Metabolic Syndrome in Patients with Psoriatic Disease","volume":"89","author":"Gelfand","year":"2012","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaad.2017.04.1133","article-title":"Systematic Review and Meta-Analysis of the Association between Psoriasis and Metabolic Syndrome","volume":"77","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the Metabolic Syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hao, Y., Zhu, Y., Zou, S., Zhou, P., Hu, Y., Zhao, Q., Gu, L., Zhang, H., Wang, Z., and Li, J. (2021). Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.711060"},{"key":"ref_22","first-page":"e6369","article-title":"Psoriasis and Metabolic Syndrome: Comorbidities and Environmental and Therapeutic Implications","volume":"11","author":"Peralta","year":"2019","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/cdr.cdr_33_21","article-title":"Psoriasis and Its Association with Metabolic Syndrome: A Case\u2013Control Study at a Tertiary Care Center in a Semi-Urban Region of South India","volume":"7","author":"Samagani","year":"2023","journal-title":"Clin. Dermatol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tupikowska-Marzec, M., Kola\u010dkov, K., Zdrojowy-We\u0142na, A., S\u0142oka, N.K., Szepietowski, J.C., and Maj, J. (2019). The Influence of FTO Polymorphism Rs9939609 on Obesity, Some Clinical Features, and Disturbance of Carbohydrate Metabolism in Patients with Psoriasis. BioMed Res. Int., 2019.","DOI":"10.1155\/2019\/7304345"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000111512","article-title":"Association between Psoriasis and the Metabolic Syndrome. A Cross-Sectional Study","volume":"216","author":"Cohen","year":"2008","journal-title":"Dermatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2147\/DMSO.S305806","article-title":"Metabolic Syndrome and Psoriasis: A Case\u2013Control Study in Kabul, Afghanistan","volume":"14","author":"Aalemi","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-Analysis of Psoriasis, Cardiovascular Disease, and Associated Risk Factors","volume":"69","author":"Miller","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bjd.13288","article-title":"Elevated Odds of Metabolic Syndrome in Psoriasis: A Population-based Study of Age and Sex Differences","volume":"172","author":"Danielsen","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Tur, E., and Maibach, H.I. (2018). Gender Differences in Psoriasis. Gender and Dermatology, Springer International Publishing.","DOI":"10.1007\/978-3-319-72156-9"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/oby.2006.83","article-title":"Waist Circumference Correlates with Metabolic Syndrome Indicators Better Than Percentage Fat","volume":"14","author":"Shen","year":"2006","journal-title":"Obesity"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of Cardiovascular Risk Factors in Patients with Psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_33","first-page":"e22119","article-title":"Body Mass Index (BMI): A Screening Tool Analysis","volume":"14","author":"Khanna","year":"2022","journal-title":"Cureus"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and Trends in Obesity among US Adults, 1999\u20132008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Czarnecka, A., Zab\u0142otna, M., Purzycka-Bohdan, D., Nowicki, R.J., and Szczerkowska-Dobosz, A. (2023). An Observational Study of 147 Psoriasis Patients: Overweightness and Obesity as a Significant Clinical Factors Correlated with Psoriasis. Medicina, 59.","DOI":"10.3390\/medicina59112006"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Polic, M., Miskulin, M., Smolic, M., Kralik, K., Miskulin, I., Berkovic, M., and Curcic, I. (2018). Psoriasis Severity\u2014A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15071486"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jdv.15159","article-title":"Psoriasis, Metabolic Syndrome and Cardiovascular Risk Factors. A Population-based Study","volume":"33","year":"2019","journal-title":"Acad. Dermatol. Venereol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s10067-019-04646-7","article-title":"Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease and Liver Stiffness in Psoriatic Arthritis and Psoriasis Patients","volume":"38","author":"Ortolan","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Nowowiejska, J., Baran, A., and Flisiak, I. (2021). Aberrations in Lipid Expression and Metabolism in Psoriasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126561"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.5114\/ada.2019.91420","article-title":"Evaluation of Serum Lipid, Lipoprotein, and Apolipoprotein Levels in Psoriatic Patients: A Systematic Review and Meta-Analysis of Case-Control Studies","volume":"36","author":"Ramezani","year":"2019","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0378-6323.115506","article-title":"Comorbidities in Psoriasis","volume":"79","author":"Aurangabadkar","year":"2013","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archdermatol.2010.370","article-title":"Prevalence of the Metabolic Syndrome in Psoriasis: Results From the National Health and Nutrition Examination Survey, 2003\u20132006","volume":"147","author":"Love","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/bjd.16885","article-title":"Metabolic Syndrome and Risk of Incident Psoriasis: Prospective Data from the HUNT Study, Norway","volume":"180","author":"Snekvik","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/PTT.S54089","article-title":"Links and Risks Associated with Psoriasis and Metabolic Syndrome","volume":"5","author":"Liakou","year":"2015","journal-title":"Psoriasis Targets Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1590\/abd1806-4841.20164655","article-title":"C-Reactive Protein Serum Level in Patients with Psoriasis before and after Treatment with Narrow-Band Ultraviolet B","volume":"91","author":"Farshchian","year":"2016","journal-title":"Ann. Bras. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.47162\/RJME.62.3.14","article-title":"Diagnostic and Prognostic Significance of Hepatic Steatosis in Patients with Chronic Hepatitis C","volume":"62","author":"Stan","year":"2021","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-3083.2010.03647.x","article-title":"Circulating Adipokine Levels in Portuguese Patients with Psoriasis Vulgaris According to Body Mass Index, Severity and Therapy","volume":"24","author":"Coimbra","year":"2010","journal-title":"Acad. Dermatol. Venereol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Holmannova, D., Borsky, P., Andrys, C., Krejsek, J., Cermakova, E., Fiala, Z., Hamakova, K., Svadlakova, T., Parova, H., and Rehacek, V. (2022). The Presence of Psoriasis, Metabolic Syndrome and Their Combination Increases the Serum Levels of CRP and CD5L but Not sCD200R1 and sTLR2 in Participants. J. Pers. Med., 12.","DOI":"10.3390\/jpm12121965"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Buonacera, A., Stancanelli, B., Colaci, M., and Malatino, L. (2022). Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073636"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bagyura, Z., Kiss, L., Lux, \u00c1., Csobay-Nov\u00e1k, C., Jermendy, \u00c1.L., Polg\u00e1r, L., Tab\u00e1k, \u00c1.G., So\u00f3s, P., Szelid, Z., and Merkely, B. (2023). Neutrophil-to-Lymphocyte Ratio Is an Independent Risk Factor for Coronary Artery Disease in Central Obesity. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087397"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/ijd.ijd_418_23","article-title":"Psoriasis and Its Association with Metabolic Syndrome","volume":"68","author":"Agarwal","year":"2023","journal-title":"Indian J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e077596","DOI":"10.1136\/bmjopen-2023-077596","article-title":"Association between the Neutrophil-to-Lymphocyte Ratio and Psoriasis: A Cross-Sectional Study of the National Health and Nutrition Examination Survey 2011\u20132014","volume":"13","author":"Hong","year":"2023","journal-title":"BMJ Open"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5114\/ada.2019.83983","article-title":"Non-Alcoholic Fatty Liver Disease in Patients with Psoriasis\u2014Therapeutic Implications","volume":"37","author":"Parcheta","year":"2020","journal-title":"Post\u0119py Dermatol. Alergol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Raman, P., and Khanal, S. (2021). Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115446"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ad.2016.12.017","article-title":"Psoriasis e h\u00edgado graso no alcoh\u00f3lico","volume":"108","author":"Carrascosa","year":"2017","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.47162\/RJME.61.2.20","article-title":"The Role of Non-Invasive Scores in Determining the Liver Fibrosis in NAFLD and Psoriatic Patients","volume":"61","author":"Neagoe","year":"2020","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","article-title":"Leptin as a Key Regulator of the Adipose Organ","volume":"23","author":"Palou","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cyto.2016.10.011","article-title":"Leptin in Inflammation and Autoimmunity","volume":"98","year":"2017","journal-title":"Cytokine"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-P\u00e9rez, A., S\u00e1nchez-Jim\u00e9nez, F., Vilari\u00f1o-Garc\u00eda, T., and S\u00e1nchez-Margalet, V. (2020). Role of Leptin in Inflammation and Vice Versa. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165887"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Costache, D., Blejan, H., Cojocaru, D., Ioni\u021b\u0103, G., Poenaru, M., Constantin, M., Costache, A., C\u0103runtu, C., Balaban, D., and Costache, R. (2024). Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet\u2014A Comprehensive Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052660"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/ITT.S240891","article-title":"The Role of IL-17 Cytokines in Psoriasis","volume":"10","author":"Mosca","year":"2021","journal-title":"ImmunoTargets Ther."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Liu, X.-Q., Zhou, P.-L., Yin, X.-Y., Wang, A.-X., Wang, D.-H., Yang, Y., and Liu, Q. (2023). Circulating Inflammatory Cytokines and Psoriasis Risk: A Systematic Review and Meta-Analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0293327"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.30526\/37.1.3148","article-title":"A Study Correlation between Levels IL-15, IL-23 and TNF-\u03b1 in a Sample of Iraqi Psoriasis Patients","volume":"37","author":"Ibraheem","year":"2024","journal-title":"Ibn AL-Haitham J. Pure Appl. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Evyana, D., Novianto, E., Budianti, W.K., Krisanti, R.I.A., Wisnu, W., Wibawanti, R., Nilasari, H., Legiawati, L., Hapsari, S.A.R., and Mutmainnah, E. (2024). Association between the Severity of Hard-to-Treat Psoriasis and the Prevalence of Metabolic Syndrome: A Hospital-Based Cross-Sectional Study in Jakarta, Indonesia. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0302391"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Singh, S., Young, P., and Armstrong, A.W. (2017). An Update on Psoriasis and Metabolic Syndrome: A Meta-Analysis of Observational Studies. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181039"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3908061","DOI":"10.1155\/2017\/3908061","article-title":"The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases","volume":"2017","author":"Kuwabara","year":"2017","journal-title":"Mediat. Inflamm."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/16\/1774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:40Z","timestamp":1760110600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/16\/1774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":66,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["diagnostics14161774"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14161774","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}